Rapid Labs News Update!

2022 has been a year of change for many of us, with the effects of COVID continuing to shape all our lives, new ways of working have been required and fresh challenges are faced with material shortages, delivery delays and freight costs skyrocketing…. Rapid Labs has also had a number of significant changes this year, [...]

2022-05-30T13:50:17+01:00May 23rd, 2022|

Meet us at Medlab 2022

After the disruption over the past 2 years we are thrilled to finally return to the Medlab Middle East Congress next week in Dubai (24-27th January). We are looking forward to meeting up with our valued distributors and meet new customers. If you are attending the event, you can find us at stand Z1- B30, [...]

2022-01-18T10:33:58+00:00January 18th, 2022|

New Catalogue for 2022

We’re pleased to share our new medical brochure for 2022. Over the past year we have added new products to our existing ranges, including dozens of new drugs of abuse tests and rapid lateral flow tests, as well as our new range of bacterial typing anti-sera and the virusPHIX molecular transport medium for virus inactivation [...]

2022-01-14T11:26:37+00:00January 6th, 2022|

Why CRP is a useful biomarker for monitoring COVID-19 Infection & Sepsis

CRP (C-reactive Protein) is an acute-phase, nonspecific marker of inflammation & infection and has been found to broadly correlate with disease severity and treatment response across a variety of infectious and non-infectious conditions1. Its rate of synthesis and secretion increases within hours of acute injury and may reach as high as 20 times the normal [...]

2021-05-24T09:41:56+01:00May 24th, 2021|

QCMD to use virusPHIX-P9™ in its SARS-CoV-2 antigen EQA scheme

QCMD will use the universal biological sample stabilisation virusPHIX-P9™ as the matrix within its forthcoming SARS-CoV-2 antigen EQA pilot scheme. Studies have proven that virusPHIX-P9™ is both capable of inactivating SARS-CoV-2 as well as stabilizing clinical samples at ambient temperatures. Extensive testing at QCMD has shown that virusPHIX-P9™ is compatible with a variety of SARS-CoV-2 [...]

2021-03-10T13:56:11+00:00March 10th, 2021|

Blood Grouping, Febrile Antigens and TPHA brochure

We are pleased to share our latest product brochure detailing our range of blood grouping (CE and non-CE), febrile antigens, latex agglutination and syphilis/TPHA screening tests. Download brochure here Rapid Labs have been producing high quality blood grouping reagents at our UK laboratory using British manufactured monoclonal cell lines for more than 12 years. We [...]

2021-03-22T14:44:09+00:00January 18th, 2021|

Recent studies show virusPHIX+ inactivates and stabilises SARS-CoV-2

We are proud to be partnering with a number of laboratories around the world for the validation of virusPHIX+™ as a viral transport medium for SARS-CoV-2 testing. Virus Inactivation A recent study from the Roslin Institute in Edinburgh, UK concluded that virusPHIX+™ inactivates SARS-CoV-2 in as little as 10 minutes when treated at a 1:1 [...]

2020-09-22T14:42:45+01:00September 22nd, 2020|